Eli Lilly and Co (NYSE:LLY)
| 425.61 Delayed Data As of May 26 |  -1.70 / -0.40%Today’s Change | 283.11 Today|||52-Week Range 454.95 | +16.34% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 2.4B | 2.7B | -204.1M | 3.2B | |
| Depreciation | 1.4B | 1.5B | 1.6B | 1.6B | ||
| Total Other Cash Flow | 603.1M | 661.4M | 1.8B | 2.7B | ||
| Funds From Operations | 3.7B | 5.3B | 2.4B | 7.9B | ||
| Funds From/For Other Operating Expenses | 918.0M | 484.1M | -3.2B | 2.4B | ||
| Net Cash Flow - Operating Activities | 2.8B | 4.9B | 5.6B | 5.5B | ||
| Investing | Increase In Investments | -4.1B | -5.7B | -8.0B | -950.1M | |
| Decrease In Investments | 5.2B | 3.7B | 7.4B | 6.1B | ||
| Capital Expenditures | -1.1B | -1.0B | -1.1B | -1.2B | ||
| Fixed Asset Disposal | 92.6M | 73.4M | 40.7M | 3.6M | ||
| Net Assets From Acquisitions | -5.3B | -45.0M | -882.1M | 0.00 | ||
| Other Investing - Uses | -133.6M | -130.1M | -215.8M | -191.3M | ||
| Other Investing - Sources | 5.8B | 0.00 | 0.00 | -- | ||
| Net Cash Flow Investing | 26.8M | -3.1B | -3.8B | 1.9B | ||
| Financing | Short Term Borrowings | -2.7B | 1.3B | 1.4B | -2.2B | |
| Long Term Borrowings | 4.5B | 1.2B | 2.2B | 2.5B | ||
| Long Term Debt Reduction | -2.0B | -200.0K | -630.6M | -1.0B | ||
| Net Proceeds Stock Sale | 0.00 | 0.00 | 0.00 | 1.7B | ||
| Common Preferred Redeemed | -749.5M | -600.1M | -299.8M | -4.2B | ||
| Common Dividends | -2.1B | -2.2B | -2.2B | -2.3B | ||
| Cash Dividends Paid - Total | -2.1B | -2.2B | -2.2B | -2.3B | ||
| Other Sources - Financing | 139.2M | -- | 0.00 | 0.00 | ||
| Other Uses - Financing | -- | 300.8M | 364.4M | 372.8M | ||
| Net Cash Flow - Financing | -2.9B | -559.8M | 142.6M | -5.9B | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -85.6M | -236.4M | -20.5M | -63.6M | |
| Net Change In Cash | -119.6M | 1.2B | 2.0B | 1.5B | ||
